Role of peiroxisome proliferators-activated receptors in the pathogenesis and treatment of nonaloholic fatty liver disease

被引:129
作者
Kallwitz, Eric R. [1 ]
McLachlan, Alan [2 ]
Cotler, Scott J. [1 ]
机构
[1] Univ Illinois, Dept Med 1, Chicago, IL USA
[2] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA
关键词
non-alcoholic fatty liver disease; peroxisome proliferators-activated receptors; insulin resiatance; metabolic syndrome; pharmacologic ligands;
D O I
10.3748/wjg.14.22
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) is highly prevalent and can result in nonalcoholic steatohepatitis (NASH) and progressive liver disease including cirrhosis and hepatocellular carcinoma. A growing body of literature implicates the peroxisome proliferators-activated receptors (PPARs) in the pathogenesis and treatment of NAFLD. These nuclear hormone receptors impact on hepatic triglyceride accumulation and insulin resistance. The aim of this review is to describe the data linking PPAR alpha and PPAR gamma to NAFLD/NASH and to discuss the use of PPAR ligands for the treatment of NASH.
引用
收藏
页码:22 / 28
页数:7
相关论文
共 108 条
[91]   INDUCTION OF THE ACYL-COENZYME-A SYNTHETASE GENE BY FIBRATES AND FATTY-ACIDS IS MEDIATED BY A PEROXISOME PROLIFERATOR RESPONSE ELEMENT IN THE C-PROMOTER [J].
SCHOONJANS, K ;
WATANABE, M ;
SUZUKI, H ;
MAHFOUDI, A ;
KREY, G ;
WAHLI, W ;
GRIMALDI, P ;
STAELS, B ;
YAMAMOTO, T ;
AUWERX, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (33) :19269-19276
[92]   PPAR alpha and PPAR gamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene [J].
Schoonjans, K ;
PeinadoOnsurbe, J ;
Lefebvre, AM ;
Heyman, RA ;
Briggs, M ;
Deeb, S ;
Staels, B ;
Auwerx, J .
EMBO JOURNAL, 1996, 15 (19) :5336-5348
[93]   Prevalence of fatty liver in children and adolescents [J].
Schwimmer, Jeffrey B. ;
Deutsch, Reena ;
Kahen, Tanaz ;
Lavine, Joel E. ;
Stanley, Christina ;
Behling, Cynthia .
PEDIATRICS, 2006, 118 (04) :1388-1393
[94]   Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance [J].
Shi, H ;
Cave, B ;
Inouye, K ;
Bjorbæk, C ;
Flier, JS .
DIABETES, 2006, 55 (03) :699-707
[95]   n-3 fatty acids do not lead to an increased diabetic risk in patients with hyperlipidemia and abnormal glucose tolerance [J].
Sirtori, CR ;
Paoletti, R ;
Mancini, M ;
Crepaldi, G ;
Manzato, E ;
Rivellese, A ;
Pamparana, F ;
Stragliotto, E .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1997, 65 (06) :1874-1881
[96]   RESPONSE OF HEPATIC MICROBODIES TO A HYPOLIPIDEMIC AGENT ETHYL CHLOROPHENOXYISOBUTYRATE (CPIB) [J].
SVOBODA, DJ ;
AZARNOFF, DL .
JOURNAL OF CELL BIOLOGY, 1966, 30 (02) :442-+
[97]   ADD1 - A NOVEL HELIX-LOOP-HELIX TRANSCRIPTION FACTOR ASSOCIATED WITH ADIPOCYTE DETERMINATION AND DIFFERENTIATION [J].
TONTONOZ, P ;
KIM, JB ;
GRAVES, RA ;
SPIEGELMAN, BM .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (08) :4753-4759
[98]   Adiponectin induces TNF-α and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli [J].
Tsatsanis, C ;
Zacharioudaki, V ;
Androulidaki, A ;
Dermitzaki, E ;
Charalampopoulos, I ;
Minas, V ;
Gravanis, A ;
Margioris, AN .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 335 (04) :1254-1263
[99]   THE MOUSE PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR RECOGNIZES A RESPONSE ELEMENT IN THE 5' FLANKING SEQUENCE OF THE RAT ACYL COA OXIDASE GENE [J].
TUGWOOD, JD ;
ISSEMANN, I ;
ANDERSON, RG ;
BUNDELL, KR ;
MCPHEAT, WL ;
GREEN, S .
EMBO JOURNAL, 1992, 11 (02) :433-439
[100]   The PPARs: From orphan receptors to drug discovery [J].
Willson, TM ;
Brown, PJ ;
Sternbach, DD ;
Henke, BR .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (04) :527-550